Research Study

First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness

Overview

Body Locations and Systems 
Corneal Disorders
ClinicalTrials.gov# 
NCT04485858
Status 
Recruiting
Study Start/End 
May 6, 2021
Locations 
Vancouver General Hospital
Name/Title 
Aleksandra Kuzmanovic, Research Coordinator
Phone 
604-875-4253
Purpose of Study 

The purpose of this study is to test the safety and efficacy of CorNeat Keratoprosthesis, a synthetic cornea, for the treatment of corneal blindness.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.